NEW DELHI, Sept 23: TPA service provider Vidal Health, a subsidiary of Bajaj Finserv Health, and world’s largest vaccine manufacturer Serum Institute of India (SII) on Tuesday announced a strategic collaboration to support national efforts in cervical cancer prevention and awareness. Starting October 1, 2025, Vidal Health’s platform will offer an end-to-end, convenient and cashless experience for human papillomavirus (HPV) vaccine – from digitally booking a doctor’s appointment at a preferred location, to providing consent and receiving certification – all with zero paperwork, a joint statement said. The fully managed health programme will provide complete support with timely dosage reminders, adherence monitoring, and efficient network management to ensure continuity of care, it sa

See Full Page